A 6-year-old boy from Tamil Nadu with known β-thalassemia major presents to the outpatient clinic with growth retardation, delayed puberty, and a fasting blood glucose of 156 mg/dL. His ferritin level is 2800 ng/mL. He has received regular transfusions since age 2 years. What is the most appropriate next step in management?

## Clinical Context This child has **secondary diabetes mellitus** (transfusional iron overload → pancreatic β-cell damage) and **secondary hypogonadism** (iron deposition in pituitary and gonads), both complications of chronic transfusion-dependent thalassemia major. ## Pathophysiology of Iron Overload Complications **Key Point:** Each unit of transfused RBCs delivers ~250 mg iron; without chelation, iron accumulates in endocrine organs (pancreas, pituitary, gonads, thyroid) and causes organ dysfunction. | Organ | Iron Deposition Effect | Clinical Manifestation | |-------|------------------------|------------------------| | Pancreas | β-cell necrosis | Diabetes mellitus | | Pituitary | Gonadotroph damage | Delayed/absent puberty, hypogonadism | | Thyroid | Follicular damage | Hypothyroidism | | Heart | Cardiomyocyte fibrosis | Dilated cardiomyopathy, arrhythmias | | Liver | Cirrhosis | Portal hypertension, HCC risk | ## Management Strategy **High-Yield:** The presence of hyperglycemia + elevated ferritin + endocrine dysfunction in a transfusion-dependent thalassemia patient mandates **iron chelation therapy** as the cornerstone intervention. 1. **Initiate iron chelation** (deferasirox, deferoxamine, or deferiprone) to reduce iron burden and halt further organ damage. 2. **Screen comprehensively** for other endocrine complications: - Thyroid function (TSH, free T4) - Gonadal axis (LH, FSH, testosterone) - Bone density (DEXA scan for osteoporosis) - Cardiac function (echocardiography, ECG) 3. **Manage hyperglycemia** with insulin once iron chelation is underway; glycemic control often improves as iron burden decreases. **Clinical Pearl:** Secondary diabetes in thalassemia is often reversible with aggressive iron chelation, unlike primary type 1 diabetes. Delaying chelation will only worsen pancreatic fibrosis and make glycemic control harder. **Mnemonic: IRON ORGANS** — **I**nsulin (pancreas), **R**eproductive (pituitary/gonads), **O**ver-load, **N**eeds chelation; **O**ther organs (heart, liver, thyroid), **R**equire screening, **G**rowth stunted, **A**ddress endocrine, **N**ow, **S**ystemic approach. ## Why Chelation First? Iron chelation addresses the **root cause** of all endocrine dysfunction. Starting insulin without chelation is treating the symptom while the underlying iron toxicity continues to damage other organs.